These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24797563)

  • 1. Highly water-soluble, porous, and biocompatible boron nitrides for anticancer drug delivery.
    Weng Q; Wang B; Wang X; Hanagata N; Li X; Liu D; Wang X; Jiang X; Bando Y; Golberg D
    ACS Nano; 2014 Jun; 8(6):6123-30. PubMed ID: 24797563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of boron nitride nanotubes and hexagonal boron nitrides as nanocarriers for cancer drugs.
    Emanet M; Şen Ö; Çulha M
    Nanomedicine (Lond); 2017 Apr; 12(7):797-810. PubMed ID: 28322118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boron nitride nanotubes functionalized with mesoporous silica for intracellular delivery of chemotherapy drugs.
    Li X; Zhi C; Hanagata N; Yamaguchi M; Bando Y; Golberg D
    Chem Commun (Camb); 2013 Aug; 49(66):7337-9. PubMed ID: 23851619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
    Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
    Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. YVO4:Eu3+ functionalized porous silica submicrospheres as delivery carriers of doxorubicin.
    Cheng Z; Ma P; Hou Z; Wang W; Dai Y; Zhai X; Lin J
    Dalton Trans; 2012 Feb; 41(5):1481-9. PubMed ID: 22124278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional upconversion mesoporous silica nanostructures for dual modal imaging and in vivo drug delivery.
    Li C; Yang D; Ma P; Chen Y; Wu Y; Hou Z; Dai Y; Zhao J; Sui C; Lin J
    Small; 2013 Dec; 9(24):4150-9. PubMed ID: 23843254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced graphene oxide nanosheets coated with an anti-angiogenic anticancer low-molecular-weight heparin derivative for delivery of anticancer drugs.
    Shim G; Kim JY; Han J; Chung SW; Lee S; Byun Y; Oh YK
    J Control Release; 2014 Sep; 189():80-9. PubMed ID: 24973719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of biodegradable porous starch foam for improving oral delivery of poorly water soluble drugs.
    Wu C; Wang Z; Zhi Z; Jiang T; Zhang J; Wang S
    Int J Pharm; 2011 Jan; 403(1-2):162-9. PubMed ID: 20937370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of kinetic stability on biodistribution and anti-tumor efficacy of drug-loaded biodegradable polymeric micelles.
    Attia AB; Yang C; Tan JP; Gao S; Williams DF; Hedrick JL; Yang YY
    Biomaterials; 2013 Apr; 34(12):3132-40. PubMed ID: 23380357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hexagonal Boron Nitrides (White Graphene): A Promising Method for Cancer Drug Delivery.
    Sharker SM
    Int J Nanomedicine; 2019; 14():9983-9993. PubMed ID: 31908454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced anti-cancer efficacy to cancer cells by doxorubicin loaded water-soluble amino acid-modified β-cyclodextrin platinum complexes.
    Zhao MX; Zhao M; Zeng EZ; Li Y; Li JM; Cao Q; Tan CP; Ji LN; Mao ZW
    J Inorg Biochem; 2014 Aug; 137():31-9. PubMed ID: 24803024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context.
    De Angelis F; Pujia A; Falcone C; Iaccino E; Palmieri C; Liberale C; Mecarini F; Candeloro P; Luberto L; de Laurentiis A; Das G; Scala G; Di Fabrizio E
    Nanoscale; 2010 Oct; 2(10):2230-6. PubMed ID: 20835434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer-lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer.
    Wong HL; Bendayan R; Rauth AM; Wu XY
    J Control Release; 2006 Dec; 116(3):275-84. PubMed ID: 17097178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer nanomedicine and tumor vascular permeability; Where is the missing link?
    Taurin S; Nehoff H; Greish K
    J Control Release; 2012 Dec; 164(3):265-75. PubMed ID: 22800576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilayer encapsulated mesoporous silica nanospheres as an oral sustained drug delivery system for the poorly water-soluble drug felodipine.
    Hu L; Sun H; Zhao Q; Han N; Bai L; Wang Y; Jiang T; Wang S
    Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():313-24. PubMed ID: 25492202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs.
    Liu SQ; Wiradharma N; Gao SJ; Tong YW; Yang YY
    Biomaterials; 2007 Mar; 28(7):1423-33. PubMed ID: 17141308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol.
    Zhang Y; Zhi Z; Li X; Gao J; Song Y
    Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrazone-bearing PMMA-functionalized magnetic nanocubes as pH-responsive drug carriers for remotely targeted cancer therapy in vitro and in vivo.
    Ding X; Liu Y; Li J; Luo Z; Hu Y; Zhang B; Liu J; Zhou J; Cai K
    ACS Appl Mater Interfaces; 2014 May; 6(10):7395-407. PubMed ID: 24749476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation and in vitro release of doxorubicin in thermally sensitive micelles made from poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide)-b-poly(D,L-lactide-co-glycolide) with varying compositions.
    Liu SQ; Tong YW; Yang YY
    Biomaterials; 2005 Aug; 26(24):5064-74. PubMed ID: 15769542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.